BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36829196)

  • 1. Molecular mechanism of Wilms' tumor (Wt1) (+/-KTS) variants promoting proliferation and migration of ovarian epithelial cells by bioinformatics analysis.
    Wang X; Zhao J; Zhang Y; Liu Y; Wang J; Shi R; Yuan J; Meng K
    J Ovarian Res; 2023 Feb; 16(1):46. PubMed ID: 36829196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor protein (-KTS) modulates renin gene transcription.
    Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
    Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
    Jomgeow T; Oji Y; Tsuji N; Ikeda Y; Ito K; Tsuda A; Nakazawa T; Tatsumi N; Sakaguchi N; Takashima S; Shirakata T; Nishida S; Hosen N; Kawakami M; Tsuboi A; Oka Y; Itoh K; Sugiyama H
    Cancer Sci; 2006 Apr; 97(4):259-70. PubMed ID: 16630117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes.
    Wells J; Rivera MN; Kim WJ; Starbuck K; Haber DA
    Mol Cancer Res; 2010 Jul; 8(7):975-85. PubMed ID: 20571064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells.
    Burwell EA; McCarty GP; Simpson LA; Thompson KA; Loeb DM
    Oncogene; 2007 May; 26(23):3423-30. PubMed ID: 17160023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms' tumor (WT1) (±KTS) variants decreases the progesterone secretion of bovine ovarian theca cells.
    Wang X; Meng K; Wang Y; Zhao Y; Lin F; Liu X; Zhang Y; Quan F
    Domest Anim Endocrinol; 2021 Jan; 74():106521. PubMed ID: 32739762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wilms' Tumor Gene WT1 - 17AA/- KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model.
    Yamanouchi K; Ohta T; Liu Z; Oji Y; Sugiyama H; Shridhar V; Matsumura S; Takahashi T; Takahashi K; Kurachi H
    Transl Oncol; 2014 Oct; 7(5):580-9. PubMed ID: 25389453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor 1 (
    Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
    Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.
    Oji Y; Tatsumi N; Kobayashi J; Fukuda M; Ueda T; Nakano E; Saito C; Shibata S; Sumikawa M; Fukushima H; Saito A; Hojo N; Suzuki M; Hoshikawa T; Shimura T; Morii E; Oka Y; Hosen N; Komatsu K; Sugiyama H
    Mol Carcinog; 2015 Dec; 54(12):1758-71. PubMed ID: 25418835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wilms tumor gene (WT1) (+/-KTS) isoforms regulate steroidogenesis by modulating the PI3K/AKT and ERK1/2 pathways in bovine granulosa cells†.
    Meng K; Wang X; He Y; Yang J; Wang H; Zhang Y; Quan F
    Biol Reprod; 2019 May; 100(5):1344-1355. PubMed ID: 30649196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.
    Nishikawa T; Wojciak JM; Dyson HJ; Wright PE
    Biochemistry; 2020 Oct; 59(40):3889-3901. PubMed ID: 32955251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new role for wilms tumor protein 1: differential activities of + KTS and -KTS variants to regulate LHβ transcription.
    Bagchi D; Andrade J; Shupnik MA
    PLoS One; 2015; 10(1):e0116825. PubMed ID: 25617744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.
    Ullmark T; Järvstråt L; Sandén C; Montano G; Jernmark-Nilsson H; Lilljebjörn H; Lennartsson A; Fioretos T; Drott K; Vidovic K; Nilsson B; Gullberg U
    Haematologica; 2017 Feb; 102(2):336-345. PubMed ID: 27612989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.
    Bor YC; Swartz J; Morrison A; Rekosh D; Ladomery M; Hammarskjöld ML
    Genes Dev; 2006 Jun; 20(12):1597-608. PubMed ID: 16738405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.
    Ullmark T; Montano G; Gullberg U
    Eur J Haematol; 2018 Mar; 100(3):229-240. PubMed ID: 29240258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
    Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
    Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
    Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
    Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico regulatory analysis for exploring human disease progression.
    Holloway DT; Kon M; DeLisi C
    Biol Direct; 2008 Jun; 3():24. PubMed ID: 18564415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.